Law Office of Brodsky & Smith, LLC Announces Investigation of Epocrates, Inc.
09 Janeiro 2013 - 12:00AM
Business Wire
Law office of Brodsky & Smith, LLC announces that it is
investigating potential claims against the Board of Directors of
Epocrates, Inc. (“Epocrates” or the “Company”) (Nasdaq: EPOC)
relating to the proposed acquisition by AthenaHealth, Inc.
(“AthenaHealth”).
Under the terms of the transaction, Epocrates shareholders will
receive only $11.75 in cash for each share of Epocrates stock they
own. The investigation concerns possible breaches of fiduciary duty
and other violations of state law by the Board of Directors of
Epocrates for not acting in the Company’s shareholders' best
interests in connection with the sale process to AthenaHealth. The
transaction may undervalue the Company and will result in a loss
for many shareholders. For example Epocrates stock traded at $25.80
as recently as March 15, 2011. In addition, an analyst has set a
price target for Epocrates stock at $15.00 per share and the
Epocrates app is used by approximately 338,000 U.S. physicians.
If you own shares of Epocrates stock and wish to discuss the
legal ramifications of the proposed transaction, or have any
questions, you may e-mail or call the law office of Brodsky &
Smith, LLC who will, without obligation or cost to you, attempt to
answer your questions. You may contact Jason L. Brodsky, Esquire or
Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza,
Suite 602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com visiting
http://brodsky-smith.com/526-epoc-epocrates-inc.html, by calling
toll free 877-LEGAL-90.
Epocrates, Inc. (MM) (NASDAQ:EPOC)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Epocrates, Inc. (MM) (NASDAQ:EPOC)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Epocrates, Inc. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Brodsky & Smith, LLC